Composition
- Active ingredients
- CLOBAZAM 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLOBAZAM 2.5MG/ML · SuspensionNDA203993-001 · Prescription
- CLOBAZAM 20MG · TabletNDA202067-003 · Prescription
- CLOBAZAM 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- CLOBAZAM 10MG · TabletNDA202067-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202067.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Onfi
- Active substance
- clobazam
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Lundbeck Pharms LLC
- Status
- Discontinued
- FDA approval
- 21 Oct 2011
- Application
- NDA202067-001